StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SWASTIVI.BO$3.86-2.53%
Fair $3.86+0.0%

SWASTIVI.BO

Swasti Vinayaka Synthetics Limited

Consumer Cyclical / Apparel ManufacturingBSE

$3.86

-0.10 (-2.53%)

Fairly Valued+0.0%Fair Value $3.86Fund rank 27/100 · Data gapFallback financials|
SA 50/C
F-Score: 2/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-13.6M · quality 46.3/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · SWASTIVI.BOLocal privado en este navegador · Swasti Vinayaka Synthetics Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$347M

P/E

15.4x

↓

EV/EBITDA

9.6x

↑

ROE

10.5%

↑

Gross Margin

29.0%

↑

Debt/Equity

0.26

↓
52-Week Range$4
$3$7

TradingView lightweight chart

SWASTIVI.BO price, volumen y niveles de valoración

Último $3.860Periodo -42.5%
Fair value: $3.860

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+23.5%

FCF CAGR

—

FCF margin

-3.5%

FCF / Net income

-0.56x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $383.8M · net income $24.2M · FCF $-13.6M

2022-FY → 2025-FY

Gross margin

29.0%-9.2% pts

Operating margin

9.9%-2.2% pts

Net margin

6.3%-2.3% pts

FCF margin

-3.5%-10.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$383.8M$383.8M$306.6M$268.2M$203.5M
Net Income$24.2M$24.2M$19.8M$19.9M$17.5M
EBITDA$41.5M$41.5M$34.5M$34.0M$28.7M
EPS0.270.270.230.230.19
Gross Margin29.0%29.0%32.7%36.7%38.2%
Operating Margin9.9%9.9%9.5%10.7%12.1%
Net Margin6.3%6.3%6.4%7.4%8.6%
Balance Sheet
Debt/Equity0.260.260.130.130.08
Cash Flow
Free Cash Flow$-13.6M$-13.6M$-29.4M$26.5M$13.8M
Returns
ROE10.5%10.5%9.6%10.7%10.5%
Valuation
P/E15.4415.44———
EV/EBITDA9.619.61———
P/B1.511.51———
Growth & Yield
Revenue Growth25.2%25.2%14.3%31.8%—
EPS Growth17.4%17.4%0.0%18.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

8.3%

razonable

EPS terminal req.

$0.34

Spread vs growth

9.1%

5Y implied EPS CAGR

8.9%

razonable

EPS terminal req.

$0.41

Spread vs growth

8.4%

10Y implied EPS CAGR

9.5%

razonable

EPS terminal req.

$0.67

Spread vs growth

7.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -38.6%

Total return

-38.6%

Start / end P/E

27.3x → 14.3x

EPS bridge

0.23 → 0.27

Residual

-8.3%

EPS growth+17.4%
Multiple rerating-47.7%
Dividend+0.0%
Residual / FX / buybacks / cross-term-8.3%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.